Variant report
Variant | esv14908 |
---|---|
Chromosome Location | chr3:195197889-195211591 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ACAP2-1 | chr3:195204068-195204142 | refGeneNc_4303_NR_033944 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181419808 | chr3:195197911-195197912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538955515 | chr3:195197917-195197918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552669236 | chr3:195197949-195197950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1873968 | chr3:195197958-195197959 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs184284896 | chr3:195198084-195198085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556681742 | chr3:195198086-195198087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189437671 | chr3:195198092-195198093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577940093 | chr3:195198096-195198097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542943762 | chr3:195198106-195198107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369005103 | chr3:195198108-195198109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573086649 | chr3:195198118-195198119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142963131 | chr3:195198136-195198137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565405224 | chr3:195198139-195198140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532495244 | chr3:195198141-195198142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114410421 | chr3:195198165-195198166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562749875 | chr3:195198207-195198208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182394408 | chr3:195198209-195198210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548493548 | chr3:195198212-195198213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560561544 | chr3:195198251-195198252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566792810 | chr3:195198256-195198257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs115613139 | chr3:195198285-195198286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552333165 | chr3:195198291-195198292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147489571 | chr3:195198323-195198324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186123004 | chr3:195198347-195198348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139322072 | chr3:195198354-195198355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568779673 | chr3:195198359-195198360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs190884899 | chr3:195198365-195198366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565080971 | chr3:195198366-195198367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2686443 | chr3:195198382-195198383 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs540478654 | chr3:195198392-195198393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs4282095 | chr3:195198396-195198397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs71291758 | chr3:195204076-195204077 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs367943417 | chr3:195204100-195204101 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs4081059 | chr3:195204118-195204119 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs71626357 | chr3:195204137-195204138 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 16751803 | CNVD |
abnormal development | 18461090 | CNVD |
Autism | 19653912 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cervical cancer | 21062161 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 16397240 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mental retardation | 17124404 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20299530 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 16760732 | CNVD |
Schizophrenia | 22118685 | CNVD |
Schizophrenia | 22958593 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 20970697 | CNVD |
Developmental delay | 18471269 | CNVD |
Intellectual disability | 22045946 | CNVD |
Breast cancer | 21045282 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Uveal melanoma | 20484589 | CNVD |
3q29 microdeletion syndrome | 20500065 | CNVD |
Biliary cancer | 20453639 | CNVD |
3q29 microdeletion syndrome | 22283845 | CNVD |
3q29 microdeletion syndrome | 21626679 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:195195400-195198200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr3:195198200-195198400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |